SCHEMBL8209067

SCHEMBL8209067

CN1C[C@H](CCNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 5/20 0.84
CYP2D6 P10635 4/20 0.84
MEN1 O00255 3/20 0.84
KMT2A Q03164 3/20 0.84
HTR7 P34969 3/20 0.84
HTR6 P50406 3/20 0.84
KDM4E B2RXH2 3/20 0.84
HTR2A P28223 3/20 0.84
USP2 O75604 2/20 0.84
TP53 P04637 2/20 0.84
CYP3A4 P08684 2/20 0.84
MAPT P10636 2/20 0.84
TSHR P16473 2/20 0.84
CYP2C19 P33261 2/20 0.84
TDP1 Q9NUW8 2/20 0.84
CYP1A2 P05177 2/20 0.84
RGS12 O14924 2/20 0.84
GNAI1 P63096 2/20 0.84
LMNA P02545 2/20 0.84
PMP22 Q01453 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metergoline SCHEMBL7631854 0.92 HTR2B (1.00) HTR2BCYP2D6MEN1KMT2AHTR7
Metergoline SCHEMBL29392365 0.92 HTR2B (1.00) HTR2BCYP2D6MEN1KMT2AHTR7
Metergoline SCHEMBL117882 0.92 HTR2B (1.00) HTR2BCYP2D6MEN1KMT2AHTR7
Metergoline SCHEMBL19236127 0.92 HTR2B (1.00) HTR2BCYP2D6MEN1KMT2AHTR7
Metergoline SCHEMBL15440536 0.92 HTR2B (1.00) HTR2BCYP2D6MEN1KMT2AHTR7
SCHEMBL2526351 0.85 HTR2B (0.76) HTR2BCYP2D6MEN1KMT2AHTR7
SCHEMBL14246888 0.84 HTR7 (0.85) HTR2BCYP2D6MEN1KMT2AHTR7
SCHEMBL184130 0.84 HTR7 (0.85) HTR2BCYP2D6MEN1KMT2AHTR7
SCHEMBL11724011 0.83 HTR2B (0.80) HTR2BCYP2D6MEN1KMT2AHTR7
SCHEMBL8209065 0.82 CYP2D6 (0.71) HTR2BCYP2D6MEN1KMT2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6026817-A ADMINISTERING OPIATE ANTAGONIST BEFORE THERAPIC DRUG NEURENDO PHARMA, LLC 2000-02-22 US disclosed